Interpace Biosciences, Inc. (IDXG) Social Stream



Interpace Biosciences, Inc. (IDXG): $2.44

0.01 (-0.41%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

INTERPACE BIOSCIENCES INC (IDXG) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering INTERPACE BIOSCIENCES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-20 1 $11 $11 $11 $0.9 1122.22%
NA 1 $NA $NA $NA $0.9 NA%

Price Target Last Issued NA NA, NA

The Trend in the Analyst Price Target


Over the past 30 weeks, IDXG's average price target has gone up $0.87.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

IDXG Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • INTERPACE BIOSCIENCES INC's number of analysts covering the stock is greater than practically none of all US stocks.
  • In the context of all US stocks, INTERPACE BIOSCIENCES INC's variance in analysts' estimates is lower than just about 100% of them.
  • In terms of how INTERPACE BIOSCIENCES INC fares relative to Medical Equipment stocks, note that its upside potential (average analyst target price relative to current price) is higher than 95.97% of that group.
  • To contextualize these metrics, consider that out of Medical Equipment stocks, INTERPACE BIOSCIENCES INC's average analyst price target is greater than 14.02% of them.

Stocks similar to INTERPACE BIOSCIENCES INC in the Medical Equipment industry regarding analyst recommendations and price targets are CERS, RVP, and SRDX.

Is IDXG a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!